Mitochondrial disorders of the nuclear genome

Acta Myologica

Volumn 28, Issue 1, 2009, Pages 16-23

  Angelini, C ^a   Bello, L ^a   Spinazzi, M ^a   Ferrati, C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Ataxia; Optic atrophy; SURF1

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CELL NUCLEUS DNA; HEME; METAL ION; MITOCHONDRIAL DNA; PROTEIN OPA 1; PROTEIN SURF 1; UBIQUINONE; UNCLASSIFIED DRUG;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME SYNTHESIS; GENE DELETION; GENE MUTATION; HUMAN; INHERITANCE; MITOCHONDRIAL MYOPATHY; PHENOTYPE; POINT MUTATION;

CELL NUCLEUS; CHILD; DNA; FEMALE; GENOME; GTP PHOSPHOHYDROLASES; HUMANS; INFANT; LEIGH DISEASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; MUTATION; OPTIC ATROPHY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; UBIQUINONE;

EID: 70349488019     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromusc Disord 2005;15:276-286
2. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692 (Pubitemid 129506238)
3. Hirano M, Nishino I, Nishigaki Y, et al. Thymidine phosphorylase gene mutations cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Intern Med 2006;45:1103.
4. Esposito LA, Melov S, Panov A, et al. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999;96:4820-4825 (Pubitemid 29214495)
5. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-785 (Pubitemid 30650199)
6. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28:223-231 (Pubitemid 32626024)
7. Lewis S, Hutchison W, Thyagarajan D, et al.. Clinical and molecular features of adPEO due to mutations in the Twinkle gene. J Neurol Sci 2002;201:39-44. (Pubitemid 34876903)
8. Nikali K, Suomalainen A, Saharinen J, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005;14:2981-2990 (Pubitemid 41535463)
9. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006;129:1674-1684 (Pubitemid 43999402)
10. Van Goethem G, Dermaut B, Lofgren A, et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001;28:211-212 (Pubitemid 32626018)
11. Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875-882 (Pubitemid 39221065)
12. Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromusc Disord 2003;13:133-142 (Pubitemid 36140008)
13. Naviaux RK, Nguyen KV POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706-712
14. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;29:342-344 (Pubitemid 33096463)
15. Mancuso M, Filosto M, Bonilla E, et al. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene. Arch Neurol 2003;60:1007-1009 (Pubitemid 36858363)
16. Oskoui M, Davidzon G, Pascual J, et al. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 2006;63:1122-1126 (Pubitemid 44232318)
17. Mancuso M, Salviati L, Sacconi S, et al. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology 2002;59:1197-1202 (Pubitemid 35192389)
18. Elpeleg O, Miller C, Hershkovitz E, et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 2005;76:1081-1086 (Pubitemid 40705442)
19. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-341 (Pubitemid 33096462)
20. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-575
21. Ugalde C, Janssen RJ, van den Heuvel LP, et al. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum Mol Genet 2004;13:659-667 (Pubitemid 38379855)
22. Kirby DM, Salemi R, Sugiana C, et al. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 2004;114:837-845 (Pubitemid 39578743)
23. Bourgeron T, Rustin P, Chretien D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-149
24. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54. (Pubitemid 32614017)
25. Fernandez-Vizarra E, Bugiani M, Goffrini P, et al. Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. Hum Mol Genet 2007;16:1241-1252 (Pubitemid 47062720)
26. Visapaa I, Fellman V, Vesa J, et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 2002;71:863-876 (Pubitemid 135750518)
27. Angelini C, Bresolin N, Pegolo G, et al. Childhood encephalomyopathy with cytochrome c oxidase deficiency, ataxia, muscle wasting, and mental impairment. Neurology 1986;36:1048-1052 (Pubitemid 16038580)
28. Pequignot MO, Dey R, Zeviani M, et al. Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome C oxidase deficiency. Hum Mutat 2001;17:374-381 (Pubitemid 32381671)
29. Papadopoulou LC, Sue CM, Davidson MM, et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999;23:333-337
30. Jaksch M, Horvath R, Horn N, et al. Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 2001;57:1440-1446 (Pubitemid 32995726)
31. Antonicka H, Mattman A, Carlson CG, et al. Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 2003;72:101-114 (Pubitemid 36056846)
32. Jaksch M, Paret C, Stucka R, et al. Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet 2001;10:3025-3035 (Pubitemid 34083489)
33. Barros MH, Carlson CG, Glerum DM, et al. Involvement of mitochondrial ferredoxin and Cox15p in hydroxylation of heme O. FEBS Lett 2001;492:133-138
34. De Meirleir L, Seneca S, Lissens W, et al. Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 2004;41:120-124 (Pubitemid 38221750)
35. Salviati L, Sacconi S, Murer L, et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 2005;65:606-608 (Pubitemid 41170725)
36. Quinzii C, Naini A, Salviati L, et al. A Mutation in Para- Hydroxybenzoate-Polyprenyl Transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 2006;78:345-349 (Pubitemid 43157573)
37. Lopez LC, Schuelke M, Quinzii CM, et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 2006;79:1125-1129 (Pubitemid 44853484)
38. Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005;105:1867-1874 (Pubitemid 40731766)
39. Kikuchi G, Shemin D, Bachmann BJ. The enzymic synthesis of delta-aminolevulinic acid. J Biol Chem 1958;233:1214-1219
40. Cotter PD, Baumann M, Bishop DF. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci USA 1992;89:4028-4032
41. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997;89:1-25. (Pubitemid 26428173)
42. Shimada Y, Okuno S, Kawai A, et al. Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia. J Hum Genet 1998;43:115-122 (Pubitemid 128508966)
43. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427 (Pubitemid 26089479)
44. Campuzano V, Montermini L, Lutz Y, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997;6:1771-1780 (Pubitemid 27460350)
45. Puccio H, Simon D, Cossee M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27:181-186 (Pubitemid 32157445)
46. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999;354:477-479 (Pubitemid 29368927)
47. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007;145:1233-1248 (Pubitemid 46602738)
48. Mancuso M, Coppede F, Migliore L, et al. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimer Dis 2006;10:59-73. (Pubitemid 44401367)
49. Trifunovic A, Larsson NG. Mitochondrial dysfunction as a cause of ageing. J Intern Med 2008;263:167-178
50. Bereiter-Hahn J, Voth M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 1994;27:198-219. (Pubitemid 24062014)
51. Fichera M, Lo Giudice M, Falco M, et al. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 2004;63:1108-1110 (Pubitemid 39287929)
52. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-220 (Pubitemid 30764505)
53. Spinazzi M, Cazzola S, Bortolozzi M, et al. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum Mol Genet 2008;17:3291-3302
54. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-451 (Pubitemid 38620027)
55. Waterham HR, Koster J, van Roermund CW, et al. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007;356:1736-1741 (Pubitemid 46658705)
56. Schaefer AM, Taylor RW, Turnbull DM, et al. The epidemiology of mitochondrial disorders: past, present and future. Biochim Biophys Acta 2004;1659:115-120 (Pubitemid 39575497)
57. Skladal D, Bernier FP, Halliday JL, et al. Birth prevalence of mitochondrial respiratory chain defects in children. J Inherit Metab Dis 2000;23;138.